Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tanaka, E.
Right arrow Articles by Wilson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, E.
Right arrow Articles by Wilson, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1994) 33, 765-775
© 1994 The British Society for Antimicrobial Chemotherapy

other

The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage

Eisaku Tanakaa, Kanthiah Kanthakumara, Diana R. Cundella, Kenneth W. T. Tsanga, Graham W. Taylorc, Fumiyuki Kuzec, Peter J. Colea and Robert Wilsona,*

aHost Defence Unit, National Heart & Lung Institute Emmanuel Kaye Building, Manresa Road, London SW36LR bRoyal Postgraduate Medical School, Hammersmith Hospital Du Cane Road, London W120HS, UK cDepartment of Infection & Inflammation, Chest Disease Research Institute, Kyoto University Kyoto, 606, Japan

Received 20 April 1993; accepted 23 November 1993

*Corresponding author

Erythromycin therapy for long periods may benefit patients with chronic bronchial sepsis colonized by Pseudomonas aeruginosa despite the lack of antibacterial activity. We have investigated the effect of filtrates of 24 h P. aeruginosa cultures (CF) with or without erythromycin 0•5, 5, 20mg/L on human nasal epithelium in the absence or presence of polymorphonuclear leucocytes (PMN). Ciliary beat frequency (CBF) and epithelium integrity were examined for 4 h. Erythromycin (20 mg/L) alone did not affect epithelium. CF without erythromycin slowed CBF by 63•5% of control at 4 h, and caused disruption of surface integrity in 80% of the epithelium. Addition of erythromycin to CF did not inhibit these effects. Erythromycin did not affect growth of P. aeruginosa. Filtrates of P. aeruginosa cultured with erythromycin (5 and 20 mg/L) caused less CBF slowing (37•2% and 19•2% of control, respectively) and epithelial disruption (4•2% and 6•7%, respectively). Unstimulated PMN (107/mL) slowed CBF by 13% of control at 4 h but did not cause epithelial disruption. PMN and CF together slowed CBF (95•4% of control) and damaged epithelium (93•3% of epithelium disrupted) synergically. Pre-incubation of PMN with erythromycin did not inhibit these effects. PMN and filtrates of P. aeruginosa cultured with erythromycin (5 and 20 mg/L) caused less CBF slowing (58•0% and 33•6% of control, respectively) and epithelial disruption (40•0% and 13•3%, respectively). Erythromycin may benefit patients by reducing P. aeruginosa production of factors which damage epithelium and stimulate neutrophil mediated cytotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Respir JHome page
K.W. Tsang, P. Ng, P.L. Ho, S. Chan, G. Tipoe, R. Leung, J. Sun, J.C. Ho, M.S. Ip, and W.K. Lam
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Eur. Respir. J., March 1, 2003; 21(3): 401 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Rutman, R. Dowling, P. Wills, C. Feldman, P. J. Cole, and R. Wilson
Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa
Antimicrob. Agents Chemother., April 1, 1998; 42(4): 772 - 778.
[Abstract] [Full Text]

Home page
 ThoraxHome page
R. Wilson and R. B Dowling
Pseudomonas aeruginosa and other related species
Thorax, March 1, 1998; 53(3): 213 - 219.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.